As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles

As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles

Trial failed of supposedly potent antibodies that the leading vaccine candidates aim to trigger (Lire plus…)

Vous lisez LMC.today gratuitement. Ce travail de veille, de tri, d’analyse et de mise en cohérence existe grâce aux soutiens. Le soutien au projet ne coûte que quelques centimes par mois.

Short link : https://lmc.today/24f9